Transdermal application of steroid to cervical trachea in patients with bronchial asthma and cough variant asthma

Transdermal application of steroid to cervical trachea in patients with bronchial asthma and cough variant asthma - Transdermal steroid treatment to tracheitis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015642

Enrollment

Registered

2014-11-09

Start date

2006-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bronchial asthma

Interventions

Trans-dermal application of steroid ointment.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Bronchial asthma (BA), cough-variant asthma (CVA) or cough predominant asthma (CPA) patients whose symptoms was not adequately controlled by their current therapy including high-dose ICS, or by limited use of ICS due to oropharyngeal side effects such as hoarseness or stomatitis.

Exclusion criteria

Exclusion criteria: Those who have dermal disease on the site of application of the drug.

Design outcomes

Primary

Measure	Time frame
response rate	—

Countries

Japan

Contacts

Public ContactMitsuhiro Kamimura

National Hospital Organization Disaster Medical Center Pulmonology Department

tdmckamimura@yahoo.co.jp042-526-5511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026